The global intrauterine contraceptive devices (IUD) marketis experiencing steady growth, driven by increasing awareness of long-term contraceptive solutions and rising demand for effective family planning methods. According to the latest market analysis, the market was valued at USD 5.18 billion in 2024 and is projected to grow from USD 5.46 billion in 2025 to USD 8.12 billion by 2033, registering a CAGR of 5.7% during the forecast period (2025–2033).
IUDs are among the most effective and reversible contraceptive methods, offering long-term protection with minimal maintenance, making them increasingly popular among women worldwide.
Key Highlights
- Base Year: 2024
- Forecast Period: 2025–2033
- Market Size 2024: USD 5.18 Billion
- Market Size 2033: USD 8.12 Billion
- CAGR: 5.7%
- Largest Region: North America
- Fastest Growing Region: Asia-Pacific (CAGR of 6.2%)
- Largest Segment (Product Type): Hormonal IUDs
- Fastest Growing Segment: Hormonal IUDs (due to higher efficacy and additional health benefits)
- Largest Segment (End-User): Hospitals
- Fastest Growing Segment: Clinics
Market Dynamics
Drivers
The growth of the intrauterine contraceptive devices market is primarily driven by increasing awareness regarding family planning and reproductive health. Governments and healthcare organizations across the globe are actively promoting the use of long-acting reversible contraceptives (LARCs), including IUDs, to reduce unintended pregnancies. The high effectiveness, convenience, and long-term protection offered by IUDs are key factors boosting their adoption.
Additionally, the rising number of working women and growing preference for reliable and low-maintenance contraceptive methods are further contributing to market growth. Continuous advancements in product design, including hormone-releasing IUDs with improved safety profiles, are also supporting increased acceptance among users.
Restraints and Opportunities
Despite favorable growth prospects, the market faces challenges such as potential side effects and lack of awareness in certain developing regions. Cultural barriers and misconceptions regarding contraceptive use may also limit market penetration. Furthermore, the need for skilled healthcare professionals for proper insertion and removal of IUDs can restrict accessibility in some areas.
However, these challenges create opportunities for market expansion. Increasing investments in women's healthcare, along with educational campaigns to raise awareness about contraceptive options, are expected to drive demand. Moreover, innovations in product development and expanding healthcare infrastructure in emerging economies are likely to open new growth avenues for market players.
Top Market Players
- Bayer AG
- CooperSurgical Inc.
- Teva Pharmaceutical Industries Ltd.
- Allergan Plc
- Pregna International Ltd.
- HLL Lifecare Limited
- Eurogine S.L.
- Mona Lisa N.V.
- SMB Corporation of India
- OCON Medical Ltd.
Market Segmentation
By Product Type
- Hormonal IUDs
- Copper IUDs
By End-User
- Hospitals
- Clinics
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- Latin America
Request Sample Report of Global Market @ https://straitsresearch.com/report/intrauterine-contraceptive-devices-iud-market/request-sample
About Us
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.
Contact Us
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
